The brand name of injectable Semaglutide licensed for Type 2 Diabetes is called "OZEMPIC"
Shima Hadidchi takes a personalized approach with every patient, working closely to determine if tirzepatide is appropriate for your specific health needs and weight loss goals
The standard schedule raises the dose every four weeks, from 2.5 mg through 5, 7.5, 10 and 12.5 mg up to the maintenance dose of 15 mg
It is worth noting that, besides the weight loss leaders, Eli Lilly and Novo Nordisk, other companies planning to enter the weight loss space are prioritizing small molecule GLP-1 drugs, as seen in the partnership between Chengyi Biotech and AstraZeneca
One consideration is that if any injection-site reactions occur (redness, swelling, mild bruising), you won't notice them until morning